Response Announces Leadership Changes
Thu, 20 Oct 2011 18:55:00 UT
Response Biomedical Corporation (TSX: RBM, OTCBB:RPBIF) announced today the appointment Dr. David Wang of Orbimed Asia to the Board of Directors of Response Biomedical, the resignation of Dr... More...
  Response Announces Restatement of Financial Statements
Fri, 30 Sep 2011 13:06:00 UT
Response Biomedical Corporation today announced that, as a result of an ongoing internal review of prior transactions and previous financial disclosure and following consultation with its e... More...
  Response Announces Termination of Sales and Distribution Agreement with Roche Diagnost...
Fri, 2 Sep 2011 12:27:00 UT
Response Biomedical Corporation (TSX:RBM, OTCBB:RPBIF) today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche... More...
  Response Announces Resignation of Chief Executive Officer
Fri, 12 Aug 2011 21:00:00 UT
Response Biomedical Corporation today announced that S. Wayne Kay, the Chief Executive Officer of Response, has tendered his resignation as both an officer and director of Response, effecti... More...
  Response Announces Second Quarter Results
Wed, 10 Aug 2011 12:51:00 UT
Response Biomedical Corporation (TSX: RBM, OTCBB: RPIBF) reported financial results for the second quarter ended June 30, 2011. For the three month period ended June 30, 2011, total revenues... More...
  Response Receives Decision Regarding CLIA Waiver for RAMP® NT-proBNP Assay for Diagnos...
Mon, 13 Jun 2011 12:00:00 UT
Response Biomedical Corporation announced that it has received a notification from the U.S. Food and Drug Administration (FDA) that its NTproBNP Assay did not meet the criteria to obtain a ... More...
  Response Announces First Quarter Results
Wed, 11 May 2011 12:30:00 UT
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470... More...
  Response Enters Into Exclusive Canadian Distribution Agreement with Fisher Scientific ...
Wed, 4 May 2011 12:00:00 UT
Response Biomedical Corporation today announced that it has entered into an exclusive distribution agreement with Fisher Scientific Company of Ottawa, Ontario, Canada to distribute the full... More...
  Response Receives SFDA Registration of RAMP® 200
Thu, 28 Apr 2011 18:05:00 UT
Response Biomedical Corporation today announced that it has received product registration from China’s State Food & Drug Administration (SFDA) to sell the RAMP® 200 Reader in the Chinese ma... More...
  Response Announces 2010 Financial Results
Fri, 11 Mar 2011 13:00:00 UT
Response Biomedical Corporation reported that it recorded total revenues of $7,610,827 compared to $9,946,269 in 2009 and reduced operating expenses by 13% to $9,216,257 in 2010 from $10,60... More...